Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant.
Šálek C, Folber F, Froňková E, Pecherková P, Jelínková H, Hrabovský Š, Horáček JM, Cetkovský P, Mayer J, Trka J, Doubek M; Czech Leukemia Study Group - for Life (CELL). Šálek C, et al. Among authors: cetkovsky p. Br J Haematol. 2022 Feb;196(3):706-710. doi: 10.1111/bjh.17966. Epub 2021 Nov 23. Br J Haematol. 2022. PMID: 34816424
Prognostic significance of mutation profile at diagnosis and mutation persistence during disease remission in adult acute myeloid leukaemia patients.
Folta A, Culen M, Jeziskova I, Herudkova Z, Tom N, Hlubinkova T, Janeckova V, Durinikova A, Vydra J, Semerad L, Dvorakova D, Remesova H, Cerovska E, Cetkovsky P, Jindra P, Szotkowski T, Zak P, Mayer J, Racil Z. Folta A, et al. Among authors: cetkovsky p. Br J Haematol. 2019 Jul;186(2):300-310. doi: 10.1111/bjh.15916. Epub 2019 Apr 9. Br J Haematol. 2019. PMID: 30968396 Free article. Clinical Trial.
WT1 Gene Expression in Peripheral Blood Before and After Allogeneic Stem Cell Transplantation is a Clinically Relevant Prognostic Marker in AML - A Single-center 14-year Experience.
Valkova V, Vydra J, Markova M, Cerovska E, Vrana M, Marinov I, Cechova H, Cetkovsky P, Vitek A, Salek C. Valkova V, et al. Among authors: cetkovsky p. Clin Lymphoma Myeloma Leuk. 2021 Feb;21(2):e145-e151. doi: 10.1016/j.clml.2020.09.008. Epub 2020 Oct 12. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33160932
Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study.
Kayser S, Hills RK, Langova R, Kramer M, Guijarro F, Sustkova Z, Estey EH, Shaw CM, Ráčil Z, Mayer J, Zak P, Baer MR, Brunner AM, Szotkowski T, Cetkovsky P, Grimwade D, Walter RB, Burnett AK, Ho AD, Ehninger G, Müller-Tidow C, Platzbecker U, Thiede C, Röllig C, Schulz A, Warsow G, Brors B, Esteve J, Russell NH, Schlenk RF, Levis MJ. Kayser S, et al. Among authors: cetkovsky p. Br J Haematol. 2021 Mar;192(5):832-842. doi: 10.1111/bjh.17336. Epub 2021 Feb 2. Br J Haematol. 2021. PMID: 33529373
Minimal residual disease detectable by quantitative assessment of WT1 gene before allogeneic stem cell transplantation in patients in first remission of acute myeloid leukemia has an impact on their future prognosis.
Válková V, Polák J, Marková M, Vítek A, Hájková H, Sálek C, Procházka B, Cetkovský P, Trněný M. Válková V, et al. Among authors: cetkovsky p. Clin Transplant. 2013 Jan-Feb;27(1):E21-9. doi: 10.1111/ctr.12046. Epub 2012 Dec 12. Clin Transplant. 2013. PMID: 23231003
A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel.
Šestáková Š, Cerovská E, Šálek C, Kundrát D, Ježíšková I, Folta A, Mayer J, Ráčil Z, Cetkovský P, Remešová H. Šestáková Š, et al. Among authors: cetkovsky p. Clin Epigenetics. 2022 Feb 11;14(1):22. doi: 10.1186/s13148-022-01242-6. Clin Epigenetics. 2022. PMID: 35148810 Free PMC article.
93 results